載入...
CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis
BACKGROUND: Although infliximab treatment is an option for patients with ulcerative colitis (UC), not all patients do respond to therapy, and cellular mechanisms leading to therapy response are incompletely known. OBJECTIVE: The objective of this article is to determine early effects of infliximab t...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4040739/ https://ncbi.nlm.nih.gov/pubmed/24917999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640613502962 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|